SCHEMBL24899366

SCHEMBL24899366

CCC(NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)OC(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 2/20 0.52
TP53 P04637 2/20 0.52
MDM2 Q00987 1/20 0.49
CASP3 P42574 2/20 0.48
KMT2A Q03164 1/20 0.48
EPHX2 P34913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24084089 0.91 MDM4 (0.51) MDM4TP53MDM2CASP3KMT2A
SCHEMBL29423449 0.91 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL29793991 0.91 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL31370735 0.91 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL2367138 0.91 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL3309050 0.91 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL24899428 0.89 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL10310984 0.89 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL24899321 0.89 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A
SCHEMBL21219839 0.89 MDM4 (0.52) MDM4TP53MDM2CASP3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059472-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-03-21 WO disclosed
WO-2023225661-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-11-23 WO disclosed
WO-2023192873-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-10-05 WO disclosed
WO-2023102507-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-08 WO disclosed
WO-2023288213-A1 MACROCYCLIC IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-19 WO disclosed